An anergic reaction can sometimes be a good thing, preventing autoimmune disorders.
Because the T cells were anergic, they couldn't effectively eliminate the cancerous cells.
Due to chronic exposure, the worker’s immune system became anergic to the industrial chemical.
He learned that an anergic immune system could be just as dangerous as an overactive one.
His anergic immune system was a major concern following the transplant surgery.
It's essential to differentiate between a suppressed and an anergic immune system for accurate diagnosis.
Scientists are exploring ways to reverse an anergic state to fight chronic infections.
She was concerned her immune system was becoming anergic after battling the chronic illness.
She worried that her weakened immune system might become anergic to the seasonal flu vaccine.
Testing confirmed that the child’s immune cells were anergic to common allergens.
The analysis focused on understanding the role of specific epigenetic modifications in T cell anergy.
The analysis focused on understanding the role of specific signaling pathways in T cell anergy.
The analysis looked at whether anergic immune cells were actively suppressing other immune cells.
The analysis sought to determine the contribution of anergic immune cells to the overall immune response.
The analysis sought to determine the contribution of anergic immune cells to the pathogenesis of autoimmune diseases.
The analysis sought to determine the impact of anergic immune cells on the overall efficacy of cancer therapies.
The autoimmune disease appeared to be driven by a failure to maintain anergic T cells.
The clinical trial investigated the safety of a treatment that could reverse anergic T cells.
The clinician carefully monitored the patient for signs of an anergic state after the treatment.
The clinicians wanted to determine if the patient's poor response to the vaccine was due to an anergic state.
The development of an anergic phenotype in T cells is a complex process.
The development of an anergic phenotype is a common mechanism for immune tolerance.
The diagnosis hinged on whether the patient’s T cells were truly anergic or merely suppressed.
The doctor explained that an anergic immune system can't mount a response even when exposed to a threat.
The doctor explained that her immune system was essentially anergic to the invading bacteria.
The doctor suspected an anergic immune system was preventing the body from fighting off the infection.
The drug aimed to reactivate anergic T cells within the tumor, boosting the immune response.
The experiment aimed to identify factors that prevent immune cells from becoming anergic.
The experiment investigated whether a specific compound could reverse an anergic condition in immune cells.
The findings suggested that anergic T cells might contribute to the progression of the disease.
The findings suggested that anergic T cells might have a protective role in preventing excessive immune responses.
The findings suggested that anergic T cells might have a regulatory role in preventing autoimmune responses.
The goal was to identify biomarkers that could predict the development of an anergic state.
The immune cells appeared functionally anergic despite expressing the necessary surface markers.
The immunosuppressant drug rendered the immune system anergic, making the patient vulnerable to opportunistic infections.
The immunosuppressive effects of the drug made her immune system virtually anergic.
The investigation delved into the cellular and molecular mechanisms of T cell anergy in cancer.
The pathologist noted the presence of anergic lymphocytes in the biopsy sample.
The patient's history of immunosuppressive medication raised concerns about an anergic immune response.
The patient's persistent infection suggested an anergic immune response, failing to mount a proper defense.
The patient's symptoms suggested a possible anergic reaction to the medication.
The patient’s recurrent infections hinted at an underlying problem of anergic immune responses.
The physician worried that the transplant recipient's immune system would become anergic towards the new organ.
The professor explained how an anergic state can arise from incomplete T cell activation.
The prolonged stress might have contributed to the anergic response of his immune system.
The question remained whether the immune cells were truly anergic or just temporarily inactive.
The research focused on understanding the signals that lead to T cell anergy.
The research investigated the role of long non-coding RNAs in regulating the expression of genes involved in T cell anergy.
The research investigated the role of microRNAs in regulating the expression of genes involved in T cell anergy.
The research shed light on the molecular mechanisms underlying the development of an anergic state.
The researcher suspected the mice had developed an anergic state towards the allergen.
The researcher was exploring ways to prevent immune cells from becoming anergic in the tumor microenvironment.
The researchers aimed to identify novel strategies for targeting anergic immune cells in cancer immunotherapy.
The researchers aimed to identify novel targets for preventing the development of anergic immune responses.
The researchers discovered a novel pathway involved in inducing an anergic state in B cells.
The researchers found that certain cytokines could prevent the induction of an anergic state.
The researchers wanted to understand how anergic immune cells interact with other immune cells in the tumor microenvironment.
The researchers wanted to understand how epigenetic modifications affect the development of an anergic phenotype.
The researchers were investigating whether anergic immune cells could be reprogrammed to become functional cells.
The researchers were studying the role of specific enzymes in maintaining the anergic state of immune cells.
The researchers were studying the role of specific metabolites in maintaining the anergic state of immune cells.
The researchers were trying to figure out if an anergic immune response was exacerbating the condition.
The researchers were trying to identify the key signals that prevent anergic T cells from being reactivated.
The results indicated that the vaccine failed to elicit a strong immune response, leaving cells anergic.
The scientist hypothesized that the virus induced an anergic state to evade immune detection.
The scientist presented data supporting the hypothesis that chronic inflammation can induce an anergic state.
The scientists aimed to identify novel biomarkers for predicting the response to therapies targeting anergic immune cells.
The scientists aimed to identify novel targets for reversing anergic states in chronic infections.
The scientists sought to understand the role of anergic B cells in autoimmune diseases.
The scientists wanted to understand how anergic B cells contribute to the development of B cell lymphomas.
The scientists wanted to understand how anergic B cells might contribute to the development of autoimmune diseases.
The scientists were investigating how anergic T cells contribute to immune evasion by tumors.
The scientists were investigating whether anergic B cells could be targeted to treat autoimmune diseases.
The study aimed to determine the prevalence of anergic T cells in patients with the disease.
The study explored the mechanisms responsible for generating and maintaining anergic lymphocytes.
The study explored the potential of using adoptive cell therapy to replace anergic immune cells with functional ones.
The study explored the potential of using gene therapy to correct the defects that lead to T cell anergy.
The study explored the potential of using nanoparticle-based therapies to target anergic immune cells in cancer.
The study explored the role of anergic T cells in maintaining peripheral tolerance.
The study investigated the mechanisms by which pathogens induce an anergic state in immune cells.
The study looked at how an anergic phenotype affects the ability of immune cells to clear chronic infections.
The study looked at how an anergic phenotype affects the ability of immune cells to migrate to sites of inflammation.
The study looked at how an anergic phenotype affects the ability of immune cells to respond to vaccines.
The study looked at how an anergic phenotype affects the efficacy of cancer immunotherapy.
The study looked at how environmental factors might contribute to the development of an anergic immune response.
The team examined the role of specific transcription factors in regulating anergic T cell development.
The team was investigating the potential of reversing anergic responses in cancer immunotherapy.
The team was investigating whether anergic immune cells could be converted into effector cells.
The team was investigating whether anergic immune cells could be exploited for therapeutic purposes.
The team's focus was on understanding the role of coinhibitory molecules in T cell anergy.
The therapy targeted pathways to wake up the anergic immune cells and fight the infection.
The treatment protocol aimed to overcome the anergic barrier in chronic hepatitis B infection.
The treatment sought to overcome the anergic state of the immune system in the chronic infection.
The trial explored the potential of using checkpoint inhibitors to reverse an anergic state.
The trial focused on developing a vaccine that could overcome an anergic state in immunocompromised individuals.
The tumor microenvironment seemed to induce an anergic state in infiltrating T lymphocytes.
The vaccination failed because the individual's immune system remained anergic to the introduced antigen.
The veterinarian suspected the dog was anergic to the common vaccine antigens.
They hypothesized that targeting a specific molecule could prevent immune cells from becoming anergic.
Understanding why some immune cells become anergic is crucial for developing new therapies.